CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci
CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci
复制标题
DOI:
10.1038/modpathol.3800982
复制
发表时间:
2008-03-01
期刊:
影响因子:
7.5
通讯作者:
Ogino, Shuji
中科院分区:
文献类型:
--
作者:
Kawasaki, Takako;Ohnishi, Mutsuko;Ogino, Shuji
The CpG island methylator phenotype (CIMP or CIMP-high) with widespread promoter methylation is a distinct phenotype in colorectal cancer. However, the concept of CIMP-low with less extensive CpG island methylation is still evolving. Our aim is to examine whether density of methylation in individual CpG islands was different between CIMP-low and CIMP-high tumors. Utilizing MethyLight technology and 889 population-based colorectal cancers, we quantified DNA methylation (methylation index, percentage of methylated reference) at 14 CpG islands, including 8 CIMP-high-specific loci (CACNA1G, CDKN2A (p16), CRABP1, IGF2, MLH1, NEUROG1, RUNX3 and SOCS1). Methylation positivity in each locus was defined as methylation index > 4. Low-level methylation (methylation index > 0, = 6/8 methylation-positive loci) and 416 CIMP-0 tumors (0/8 methylation-positive loci) (P